Mexico's path towards the Sustainable Development Goal for health: an assessment of the feasibility of reducing premature mortality by 40% by 2030

Eduardo González-Pier, Mariana Barraza-Lloréns, Naomi Beyeler, Dean Jamison, Felicia Knaul, Rafael Lozano, Gavin Yamey, Jaime Sepúlveda

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background The United Nations Sustainable Development Goal for health (SDG3) poses complex challenges for signatory countries that will require clear roadmaps to set priorities over the next 15 years. Building upon the work of the Commission on Investing in Health and published estimates of feasible global mortality SDG3 targets, we analysed Mexico's mortality to assess the feasibility of reducing premature (0–69 years) mortality and propose a path to meet SDG3. Methods We developed a baseline scenario applying 2010 age-specific and cause-specific mortality rates from the Mexican National Institute of Statistics and Geography (INEGI) to the 2030 UN Population Division (UNPD) population projections. In a second scenario, INEGI age-specific and cause-specific trends in death rates from 2000 to 2014 were projected to 2030 and adjusted to match the UNPD 2030 mortality projections. A third scenario assumed a 40% reduction in premature deaths across all ages and causes. By comparing these scenarios we quantified shortfalls in mortality reductions by age group and cause, and forecasted life expectancy pathways for Mexico to converge to better performing countries. Findings UNPD-projected death rates yield a 25·9% reduction of premature mortality for Mexico. Accelerated reductions in adult mortality are necessary to reach a 40% reduction by 2030. Mortality declines aggregated across all age groups mask uneven gains across health disorders. Injuries, particularly road traffic accidents and homicides, are the main health challenge for young adults (aged 20–49 years) whereas unabated diabetes mortality is the single most important health concern for older adults (aged 50–69 years). Interpretation Urgent action is now required to control non-communicable diseases and reduce fatal injuries in Mexico, making a 40% reduction in premature mortality by 2030 feasible and putting Mexico back on a track of substantial life expectancy convergence with better performing countries. Our study provides a roadmap for setting national health priorities. Further analysis of the equity implications of following the suggested pathway remains a subject of future research. Funding Mexico's Ministry of Health, University of California, San Francisco, and Bill & Melinda Gates Foundation.

Original languageEnglish (US)
Pages (from-to)e714-e725
JournalThe Lancet Global Health
Volume4
Issue number10
DOIs
StatePublished - Oct 1 2016

Fingerprint

Premature Mortality
Conservation of Natural Resources
Mexico
Mortality
Health
United Nations
Life Expectancy
Age Groups
Population
Communicable Disease Control
Health Priorities
Geography
San Francisco
Traffic Accidents
Homicide
Wounds and Injuries
Masks
Young Adult

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mexico's path towards the Sustainable Development Goal for health : an assessment of the feasibility of reducing premature mortality by 40% by 2030. / González-Pier, Eduardo; Barraza-Lloréns, Mariana; Beyeler, Naomi; Jamison, Dean; Knaul, Felicia; Lozano, Rafael; Yamey, Gavin; Sepúlveda, Jaime.

In: The Lancet Global Health, Vol. 4, No. 10, 01.10.2016, p. e714-e725.

Research output: Contribution to journalArticle

González-Pier, Eduardo ; Barraza-Lloréns, Mariana ; Beyeler, Naomi ; Jamison, Dean ; Knaul, Felicia ; Lozano, Rafael ; Yamey, Gavin ; Sepúlveda, Jaime. / Mexico's path towards the Sustainable Development Goal for health : an assessment of the feasibility of reducing premature mortality by 40% by 2030. In: The Lancet Global Health. 2016 ; Vol. 4, No. 10. pp. e714-e725.
@article{b82d17f1297c4f1694dada40a9e981c8,
title = "Mexico's path towards the Sustainable Development Goal for health: an assessment of the feasibility of reducing premature mortality by 40{\%} by 2030",
abstract = "Background The United Nations Sustainable Development Goal for health (SDG3) poses complex challenges for signatory countries that will require clear roadmaps to set priorities over the next 15 years. Building upon the work of the Commission on Investing in Health and published estimates of feasible global mortality SDG3 targets, we analysed Mexico's mortality to assess the feasibility of reducing premature (0–69 years) mortality and propose a path to meet SDG3. Methods We developed a baseline scenario applying 2010 age-specific and cause-specific mortality rates from the Mexican National Institute of Statistics and Geography (INEGI) to the 2030 UN Population Division (UNPD) population projections. In a second scenario, INEGI age-specific and cause-specific trends in death rates from 2000 to 2014 were projected to 2030 and adjusted to match the UNPD 2030 mortality projections. A third scenario assumed a 40{\%} reduction in premature deaths across all ages and causes. By comparing these scenarios we quantified shortfalls in mortality reductions by age group and cause, and forecasted life expectancy pathways for Mexico to converge to better performing countries. Findings UNPD-projected death rates yield a 25·9{\%} reduction of premature mortality for Mexico. Accelerated reductions in adult mortality are necessary to reach a 40{\%} reduction by 2030. Mortality declines aggregated across all age groups mask uneven gains across health disorders. Injuries, particularly road traffic accidents and homicides, are the main health challenge for young adults (aged 20–49 years) whereas unabated diabetes mortality is the single most important health concern for older adults (aged 50–69 years). Interpretation Urgent action is now required to control non-communicable diseases and reduce fatal injuries in Mexico, making a 40{\%} reduction in premature mortality by 2030 feasible and putting Mexico back on a track of substantial life expectancy convergence with better performing countries. Our study provides a roadmap for setting national health priorities. Further analysis of the equity implications of following the suggested pathway remains a subject of future research. Funding Mexico's Ministry of Health, University of California, San Francisco, and Bill & Melinda Gates Foundation.",
author = "Eduardo Gonz{\'a}lez-Pier and Mariana Barraza-Llor{\'e}ns and Naomi Beyeler and Dean Jamison and Felicia Knaul and Rafael Lozano and Gavin Yamey and Jaime Sep{\'u}lveda",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/S2214-109X(16)30181-4",
language = "English (US)",
volume = "4",
pages = "e714--e725",
journal = "The Lancet Global Health",
issn = "2214-109X",
publisher = "Elsevier BV",
number = "10",

}

TY - JOUR

T1 - Mexico's path towards the Sustainable Development Goal for health

T2 - an assessment of the feasibility of reducing premature mortality by 40% by 2030

AU - González-Pier, Eduardo

AU - Barraza-Lloréns, Mariana

AU - Beyeler, Naomi

AU - Jamison, Dean

AU - Knaul, Felicia

AU - Lozano, Rafael

AU - Yamey, Gavin

AU - Sepúlveda, Jaime

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Background The United Nations Sustainable Development Goal for health (SDG3) poses complex challenges for signatory countries that will require clear roadmaps to set priorities over the next 15 years. Building upon the work of the Commission on Investing in Health and published estimates of feasible global mortality SDG3 targets, we analysed Mexico's mortality to assess the feasibility of reducing premature (0–69 years) mortality and propose a path to meet SDG3. Methods We developed a baseline scenario applying 2010 age-specific and cause-specific mortality rates from the Mexican National Institute of Statistics and Geography (INEGI) to the 2030 UN Population Division (UNPD) population projections. In a second scenario, INEGI age-specific and cause-specific trends in death rates from 2000 to 2014 were projected to 2030 and adjusted to match the UNPD 2030 mortality projections. A third scenario assumed a 40% reduction in premature deaths across all ages and causes. By comparing these scenarios we quantified shortfalls in mortality reductions by age group and cause, and forecasted life expectancy pathways for Mexico to converge to better performing countries. Findings UNPD-projected death rates yield a 25·9% reduction of premature mortality for Mexico. Accelerated reductions in adult mortality are necessary to reach a 40% reduction by 2030. Mortality declines aggregated across all age groups mask uneven gains across health disorders. Injuries, particularly road traffic accidents and homicides, are the main health challenge for young adults (aged 20–49 years) whereas unabated diabetes mortality is the single most important health concern for older adults (aged 50–69 years). Interpretation Urgent action is now required to control non-communicable diseases and reduce fatal injuries in Mexico, making a 40% reduction in premature mortality by 2030 feasible and putting Mexico back on a track of substantial life expectancy convergence with better performing countries. Our study provides a roadmap for setting national health priorities. Further analysis of the equity implications of following the suggested pathway remains a subject of future research. Funding Mexico's Ministry of Health, University of California, San Francisco, and Bill & Melinda Gates Foundation.

AB - Background The United Nations Sustainable Development Goal for health (SDG3) poses complex challenges for signatory countries that will require clear roadmaps to set priorities over the next 15 years. Building upon the work of the Commission on Investing in Health and published estimates of feasible global mortality SDG3 targets, we analysed Mexico's mortality to assess the feasibility of reducing premature (0–69 years) mortality and propose a path to meet SDG3. Methods We developed a baseline scenario applying 2010 age-specific and cause-specific mortality rates from the Mexican National Institute of Statistics and Geography (INEGI) to the 2030 UN Population Division (UNPD) population projections. In a second scenario, INEGI age-specific and cause-specific trends in death rates from 2000 to 2014 were projected to 2030 and adjusted to match the UNPD 2030 mortality projections. A third scenario assumed a 40% reduction in premature deaths across all ages and causes. By comparing these scenarios we quantified shortfalls in mortality reductions by age group and cause, and forecasted life expectancy pathways for Mexico to converge to better performing countries. Findings UNPD-projected death rates yield a 25·9% reduction of premature mortality for Mexico. Accelerated reductions in adult mortality are necessary to reach a 40% reduction by 2030. Mortality declines aggregated across all age groups mask uneven gains across health disorders. Injuries, particularly road traffic accidents and homicides, are the main health challenge for young adults (aged 20–49 years) whereas unabated diabetes mortality is the single most important health concern for older adults (aged 50–69 years). Interpretation Urgent action is now required to control non-communicable diseases and reduce fatal injuries in Mexico, making a 40% reduction in premature mortality by 2030 feasible and putting Mexico back on a track of substantial life expectancy convergence with better performing countries. Our study provides a roadmap for setting national health priorities. Further analysis of the equity implications of following the suggested pathway remains a subject of future research. Funding Mexico's Ministry of Health, University of California, San Francisco, and Bill & Melinda Gates Foundation.

UR - http://www.scopus.com/inward/record.url?scp=84991696927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991696927&partnerID=8YFLogxK

U2 - 10.1016/S2214-109X(16)30181-4

DO - 10.1016/S2214-109X(16)30181-4

M3 - Article

C2 - 27596038

AN - SCOPUS:84991696927

VL - 4

SP - e714-e725

JO - The Lancet Global Health

JF - The Lancet Global Health

SN - 2214-109X

IS - 10

ER -